Marshall Wace North America’s Ocular Therapeutix OCUL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	$160K	Buy	+15,971	New	+$160K	﹤0.01%	1280
2018 Q1	–	Sell	-25,133	Closed	-$112K	–	1615
2017 Q4	$112K	Buy	+25,133	New	+$112K	﹤0.01%	1307